globalbarry. Company Intelligence Engine

Kalaris Therapeutics, Inc.

KLRS CIK 0001754068 · Biological Products, (No Diagnostic Substances) (SIC 2836)

Disclosed SEC business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922

Kalaris Therapeutics, Inc. (ticker KLRS, CIK 0001754068) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Biological Products, (No Diagnostic Substances) (SIC 2836). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.

51 exposure relationships mapped 51 related entities (events · industries · countries) Intelligence last refreshed 2026-11-04

Top findings public preview

  • FACT Disclosed industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
  • FACT Country of disclosed business address: United States
  • FACT 4 filed (period 2026-08-27) 2026-08-28 source ↗

Go deeper

This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 2 free company deep views left this month.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.